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Abstract
Objective:  To  evaluate  the  initial  Dornic  acidity  in  raw  human  milk,  after  pasteurization  and
after heating  and  dilution  of  a  dietary  supplement  for  preterm  infants.
Methods:  A  quantitative,  descriptive,  and  experimental  study  was  carried  out  with  a  conve-
nience sample  at  the  human  milk  bank  at  a  Brazilian  public  maternity,  with  specialized  care
for pregnant  women  and  newborns  at  risk.  The  eligibility  criteria  for  the  study  sample  included
93 frozen  raw  human  milk  in  suitable  containers  with  volumes  ≥100  mL  and  initial  Dornic  acid-
ity ≤8◦ Dornic  (◦ D).  Milk  acidity  of  human  milk  was  measured  in  four  stages:  in  raw  human
milk (initial);  after  pasteurization;  after  the  heating  of  pasteurized  milk  and  dilution  of  the
supplement;  and  after  thirty  minutes  of  supplementation.
Results:  The  initial  acidity  was  3.8◦ D  ±  1.3  (95%  CI:  3.56--4.09)  with  no  signiﬁcant  difference
in Dornic  acidity  in  pasteurized  milk,  which  was  3.6◦ D  ±  1.2  (95%  CI:  3.36--3.87).  The  dilution
of the  supplement  in  pasteurized  milk  that  was  heated  signiﬁcantly  increased  mean  Dornic
acidity to  18.6 ◦D  ±  2.2  (95%  CI:  18.18--19.11),  which  remained  high  after  thirty  minutes  of
supplementation  at  17.8 ◦D  ±  2.2  (95%  CI:  17.36--18.27),  considering  p  <  0.05.
Conclusions:  The  study  observed  no  signiﬁcant  differences  in  Dornic  acidity  of  raw  human  milk
and pasteurized  human  milk;  however,  the  dilution  of  a  human  milk  supplementation  caused  a
signiﬁcant increase  in  acidity.  Further  investigations  are  necessary  on  the  inﬂuence  of  this  ﬁnd-
ing on  the  quality  of  supplemented  milk  and  its  consequences  on  the  health  of  preterm  infants.
© 2016  Published  by  Elsevier  Editora  Ltda.  on  behalf  of  Sociedade  Brasileira  de  Pediatria.  This  is
an open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/
by-nc-nd/4.0/).
 Please cite this article as: Pereira CI, Dametto JF, Oliveira JC. Evaluation of human milk titratable acidity before and after addition of
a nutritional supplement for preterm newborns. J Pediatr (Rio J). 2016;92:499--504.
 Study conducted at Universidade Federal do Rio Grande do Norte (UFRN), Natal, RN, Brazil.
∗ Corresponding author.
E-mail: cibelle iaskara@yahoo.com.br (C.I. Pereira).
http://dx.doi.org/10.1016/j.jped.2015.12.008
0021-7557/© 2016 Published by Elsevier Editora Ltda. on behalf of Sociedade Brasileira de Pediatria. This is an open access article under
the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
500  Pereira  CI  et  al.
PALAVRAS-CHAVE
Recém-nascido;
Leite  humano;
Acidez  titulável;
Suplementos
nutricionais;
Doenc¸as ósseas
metabólicas
Avaliac¸ão  da  acidez  titulável  do  leite  humano  antes  e  após  adic¸ão  de  um  suplemento
nutricional  para  recém-nascido  pré-termo
Resumo
Objetivo:  Avaliar  a  acidez  Dornic  inicial  no  leite  humano  cru,  após  pasteurizac¸ão  e  após  aque-
cimento e  diluic¸ão  de  um  suplemento  nutricional  para  recém-nascidos  prematuros.
Métodos:  Estudo  quantitativo,  descritivo,  experimental  com  amostragem  por  conveniência,
realizado  no  Banco  de  Leite  Humano  de  uma  maternidade  pública  brasileira,  com  assistên-
cia especializada  às  gestantes  e  recém-nascidos  de  risco.  Os  critérios  de  elegibilidade  das  93
amostras  do  estudo  incluíram  leites  humanos  crus  congelados  em  embalagens  apropriadas,  com
volumes ≥  100  mL  e  acidez  Dornic  inicial  ≤  8◦Dornic  (◦D).  A  acidez  Dornic  dos  leites  humanos  foi
mensurada  em  quatro  momentos:  no  leite  humano  cru  (inicial);  após  pasteurizac¸ão;  após  aque-
cimento  do  leite  pasteurizado  e  diluic¸ão  do  suplemento;  e  após  transcorridos  trinta  minutos  de
suplementac¸ão.
Resultados:  A  acidez  inicial  foi  de  3,8◦D  ±  1,3  (IC  3,56--4,09)  não  apresentando  diferenc¸a  signi-
ﬁcativa em  relac¸ão  à  acidez  Dornic  no  leite  pasteurizado,  que  foi  3,6◦D  ±  1,2  (IC  3,36--3,87).  A
diluic¸ão do  suplemento  no  leite  pasteurizado  e  aquecido  aumentou  signiﬁcativamente  a  média
da acidez  Dornic  a  18,6◦D  ±  2,2  (IC  18,18--19,11),  a  qual  se  manteve  elevada  em  17,8◦D  ±  2,2
(IC 17,36--18,27)  após  30  minutos  da  diluic¸ão,  considerando  p  <  0,05.
Conclusões:  O  estudo  demonstrou  que  a  acidez  Dornic  do  leite  humano  cru  e  do  leite  humano
pasteurizado  não  apresentaram  diferenc¸as  signiﬁcativas  entre  si,  porém,  a  diluic¸ão  do  suple-
mento de  leite  humano  promoveu  elevac¸ão  signiﬁcativa  da  acidez.  Maiores  investigac¸ões  da
inﬂuência desse  achado  sobre  a  qualidade  do  leite  suplementado  e  suas  consequências  na  saúde
de prematuros  são  necessárias.
© 2016  Publicado  por  Elsevier  Editora  Ltda.  em  nome  de  Sociedade  Brasileira  de  Pediatria.  Este
e´ um  artigo  Open  Access  sob  uma  licenc¸a  CC  BY-NC-ND  (http://creativecommons.org/licenses/
by-nc-nd/4.0/).
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he  technological  advances  of  the  20th  century  in  the  area
f  Neonatology  allowed  for  the  creation  of  Neonatal  Inten-
ive  Care  Units  and  favored  the  survival  of  preterm  and  very
ow  birth  weight  (VLBW)  newborns.1 This  reality  has  imposed
everal  challenges  on  the  care  of  this  population,  which
equires  greater  attention  in  relation  to  growth,  develop-
ent,  and  nutrition.2
Regarding  the  dietary  aspects,  the  World  Health  Organi-
ation  recommends  the  use  of  the  mother’s  own  milk  also
or  preterm  infants,  as  in  addition  to  being  better  toler-
ted  due  to  its  easy  digestibility,  it  also  has  high  nutritional
uality  and  beneﬁts  the  mother--child  binomial  through
reastfeeding.3 It  also  aids  the  immune  protection  against
nfections,  sepsis,  and  necrotizing  enterocolitis,  favors  the
reterm  infant’s  mental  development,4 and  appears  to  mod-
late  risk  factors  for  cardiovascular  diseases  in  the  long
erm,4 constituting  a  powerful  option  among  the  strategies
o  reduce  child  mortality.5
As  for  the  nutritional  composition,  the  human  milk
HM)  of  a  preterm  infant’s  mother  initially  has  a  higher
oncentration  of  protein,  lipids,  minerals  (such  as  sodium,
alcium  and  phosphorus),  electrolytes,  and  immunological
roperties,  when  compared  to  the  milk  of  a  full-term
ewborn’s  mother;  but  at  the  end  of  the  ﬁrst  month,  these
ifferences  decrease,  making  the  milk  of  a  preterm  infant’s
other  resemble  that  of  a  full-term  infant’s.6,7 With  a
ecrease  in  the  nutritional  reserves  of  preterm  infants,  in
ontrast  with  their  high  metabolic  demands,  inadequate
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outritional  support  can  lead  to  adverse  and  permanent
ffects  on  their  growth  and  development.3
Therefore,  HM  supplementation  has  been  indicated  to
eet  the  nutritional  requirements  of  this  population,  and
o  prevent  or  treat  metabolic  bone  diseases  in  these
ndividuals,3,8 a  well-established  nutritional  practice  in
eonatology.9 Among  the  HM  supplements  used  in  Brazil,
hose  based  on  bovine  whey  protein  hydrolysates,  combined
ith  several  vitamins  and  minerals  (especially  calcium,
hosphorus,  and  potassium),  are  most  commonly  used.10
In  spite  of  recommendations  for  supplementation  of  the
reterm  mother’s  own  milk,  if  the  nursing  mother  cannot
eet  the  baby’s  requirements,  the  administration  of  milk
rom  a  HM  bank  (HMB)  is  proposed.5,11 In  this  case,  it  under-
oes  strict  quality  control  before  distribution,  among  which
s  the  measurement  of  Dornic  acidity  (DA).  Variations  within
he  range  of  1.0--8.0  Dornic  degrees  (◦ D)  classify  the  food  for
onsumption,  whereas  higher  values  disqualify  it  from  the
icrobiological  point  of  view  and  may  also  inﬂuence  the  bio-
ogical  availability  of  nutrients,  such  as  calcium,12,13 which
s  essential  for  bone  mineralization  in  preterm  infants.14,15
The  initial  DA  of  HM  is  determined  by  its  chemical  compo-
ition,  with  special  contribution  of  proteins,  phosphates,
itrates,  and  carbon  dioxide,16,17 in  addition  to  organic
cids17;  when  a  supplement  containing  these  components  is
dded,  it  can  cause  changes  in  that  acidity  by  changing  the
oncentrations  of  such  components  in  HM.16 However,  there
re  no  studies  on  the  assessment  of  DA  in  supplemented
M;  moreover,  aspects  about  the  effectiveness  and  safety
f  nutritional  supplements  for  HM  for  preterm  infants  are
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pAcidity  in  HM  with  and  without  nutritional  supplement  
not  yet  fully  understood,9 justifying  the  performance  of  this
study.
In  light  of  this  problem,  the  present  study  aimed  to  eval-
uate  the  initial  DA  in  raw  HM  after  pasteurization  and  after
heating  and  dilution  of  the  supplement  used  to  complement
very-low  birth  weight  preterm  infants’  nutrition  and/or
those  undergoing  treatment  for  metabolic  bone  diseases,
to  verify  whether  there  are  ﬂuctuations  in  the  behavior  of
the  DA  variable,  considering  these  food  handling  steps.
Methods
This  was  a  quantitative,  descriptive,  experimental  study
with  a  convenience  sampling,  conducted  in  the  state  ref-
erence  HMB  of  Maternidade  Escola  Januário  Cicco  in  Natal,
state  of  Rio  Grande  do  Norte,  Brazil,  which  is  part  of  the
Brazilian  Uniﬁed  Health  System  and  provides  specialized
care  to  at-risk  pregnant  women,  mothers,  and  newborns.
The  HM  collected  and  pasteurized  on  site  are  intended  to
beneﬁt  preterm  newborns  in  the  Neonatal  Intensive  Care
Unit  of  the  hospital  and  rooming-in  wards.
The  study  was  approved  by  the  Research  Ethics  Com-
mittee  of  the  school  maternity  and  Hospital  Universitário
Onofre  Lopes,  of  the  hospital  complex  of  Universidade  Fed-
eral  do  Rio  Grande  do  Norte.
Sample  collection  was  preceded  by  signing  an  institu-
tional  authorization  form  and  took  place  over  24  days,  during
the  afternoon  shift,  between  the  months  of  August  and  Octo-
ber  2014.
To  estimate  the  number  of  samples,  the  sample  size  was
simulated  in  relation  to  the  assessed  effect  size,  based
on  two  ﬁxed  parameters:  alpha  =  0.05  (5%  of  statistical
probability  to  reject  the  null  hypothesis)  and  statistical
power  =  0.8  (test  power  to  detect  a  genuine,  actual  effect,
if  it  exists).  Also,  without  predicting  a  direction,  the  differ-
ence  between  the  means  was  investigated  from  a  two-tailed
analysis.  It  was  observed  that  for  an  expected  effect  of  0.5
(mean  effect  according  to  Cohen),  it  would  be  necessary  to
collect  a  minimum  sample  size  of  34  elements.
Study  eligibility  criteria  included  104  samples  of  raw  HM
from  nursing  mothers  that  had  expressed  their  milk  at  home,
in  the  HM  collection  room  at  the  school  maternity,  or  at
the  HMB;  were  received  for  pasteurization  frozen  in  glass
containers  with  plastic  lids,  with  volumes  >100  mL  and  an
initial  DA  <  8◦ D.  The  exclusion  criteria  were  the  occurrence
of  repetition  samples  (from  the  same  donor)  and  failure  to
follow  the  steps  established  by  the  study  methodology  with
a  given  sample.  There  were  11  sample  losses,  totaling  93
assessed  samples.
N/9  sodium  hydroxide  (N/9  NaOH--Dornic  solution)  was
used  as  the  titrant  solution  to  determine  the  DA  of  the  HM.
Each  0.01  mL  used  to  neutralize  1  mL  of  HM  corresponded
to  1◦ D  (one  Dornic  degree).  For  the  detection  of  the  tur-
ning  point,  one  drop  of  phenolphthalein  indicator  solution
in  hydroalcoholic  solution  at  1%  was  added,  which  initially
appeared  as  a  clear  solution  and,  after  the  pH  turned,
became  light  pink  in  color,  indicating  the  pH  change.  Sub-
sequently,  the  spent  titrant  volume  was  read  using  an  acid
meter.12,13
The  nutritional  supplement  added  to  HM  was  a  commer-
cial  nutrient  powder  formula  for  at-risk  newborns,  based  on
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ovine  whey  protein  hydrolysate,  maltodextrin,  vitamins,
nd  minerals;  a  single  type  was  used  for  all  evaluations
arried  out  in  study.  According  to  the  protocol  of  nutri-
ion  and  dietetics  of  the  maternity  service,  the  HM  was
eated  to  37 ◦C  before  the  multicomponent  supplement  dilu-
ion.  The  manufacturer’s  recommendations  were  followed
egarding  product  dilution  (1  g/20  mL  HM),  although  at  the
roportional  amount  of  0.05  g  for  1  mL  of  HM  used  in  the
easurements.
In  the  case  of  very-low  birth  weight  preterm  infants,
hose  sucking  and  swallowing  reﬂexes  are  delayed  due  to
he  neurological  system  immaturity,  it  becomes  impossible
o  carry  out  the  continuous  and  prompt  diet  administration
nd  the  supplemented  milk  is  not  fully  consumed  at  once.
hort  intervals  during  the  diet  administration  are  required  to
revent  reﬂux  and/or  bronchoaspiration,  both  in  the  case  of
ffering  the  food  using  a  dosing  cup  directly  to  the  mouth  of
reterm  infant,  and  through  enteral  feeding  for  those  who
annot  be  fed  orally.
Considering  the  consequences  of  the  interval  between
reparation  and  the  completion  of  the  administration,  as
ell  as  the  stages  of  its  previous  handling,  the  DA  of  the  HM
ncluded  in  the  study  was  measured  at  four  different  times  in
rder  to  characterize  its  possible  ﬂuctuations:  in  the  raw  HM
initial  acidity);  after  pasteurization;  after  the  pasteurized
M  was  heated  and  nutritional  supplement  was  diluted;  and
0  (thirty)  minutes  after  HM  supplementation.
The  ﬁrst  moment  (DA  measured  in  raw  HM)  was  based  on
ata  collection  of  samples  by  consulting  the  HMB  records,
s  the  activity  is  developed  and  recorded  daily  by  local  pro-
essionals.  The  researchers  were  responsible  for  carrying  out
he  measurements  at  the  second,  third,  and  fourth  moments
f  the  study.
The  data  collected  from  the  samples  were  stored  in  a
peciﬁc  form  and  subsequently  stored  in  Microsoft  Excel®
preadsheets  (Microsoft  Excel®,  V  2010.  Microsoft®,  WA,
SA).  The  DA  of  samples  at  the  respective  moments  of  the
tudy  was  measured  in  triplicate,  using  the  arithmetic  mean
f  the  values  obtained  from  the  individual  analysis  of  each
liquot.  The  mean  DA  obtained  at  the  appropriate  study
oments  were  used  for  the  statistical  tests.
The  one-way  ANOVA  statistical  test  was  applied  to  deter-
ine  the  variability  between  the  means  of  each  stage  of  the
tudy;  Tukey’s  post-test  was  then  used  for  multiple  compar-
sons.  The  level  of  signiﬁcance  was  set  at  5%.
esults
t  ﬁrst,  the  statistical  test  showed  that  at  least  one  of  the
roups  had  a  statistically  signiﬁcant  difference  compared  to
he  others  (p  <  0.0001).
The  post-test  indicated  no  signiﬁcant  difference
p  >  0.05)  between  DA  in  raw  HM  and  after  pasteurization.
owever,  the  mean  DA  in  raw  HM  showed  a  statistically
igniﬁcant  difference  (p  <  0.05)  in  DA  means  after  the
asteurized  HM  was  heated  and  the  nutritional  supplement
as  added  when  compared  with  the  DA  registered  30  min
fter  supplementation.
A difference  was  also  observed  between  the  means  of
A  after  HM  pasteurization,  the  DA  of  pasteurized  HM  after
502  Pereira  CI  et  al.
Table  1  Mean,  standard  deviation,  standard  error  of  the  mean,  and  variation  above  and  below  the  95%  conﬁdence  intervals  of
Dornic acidity  of  human  milk  at  each  stage  of  the  study.
Groups  Mean  Standard
deviation
Standard  error
of  the  mean
95%  below  the
conﬁdence  interval
95%  above  the
conﬁdence  interval
Dornic  acidity  in  raw  milk  (initial)  3.8a 1.3  0.14  3.56  4.09
Dornic acidity  after  pasteurization  3.6a 1.2  0.13  3.36  3.87
Dornic post-heating  and  supplement
addition
18.6b 2.2  0.23  18.18  19.11
Dornic acidity  after  30  min  of
supplementation
17.8c 2.2  0.23  17.36  18.27
 (p < 0
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wa,b,c Different letters represent statistically signiﬁcant difference
eating  and  supplement  addition  and  DA  30  min  after  supple-
entation,  as  shown  in  Table  1.
iscussion
ilk  is  a  buffer  solution,  with  a  low  concentration  of  free
ydrogen  ions  (H+).  Because  of  the  buffer  resulting  from  its
ntrinsic  composition,  small  changes  detected  in  pH  values
re  preceded  by  considerable  increases  in  DA.12,18
About  the  association  between  these  two  chemical
arameters,  in  general  it  is  considered  that  DA  is  more  sensi-
ive  to  the  total  content  of  solutes  in  HM  and  that  the  lower
he  pH,  the  higher  the  DA  of  the  food.  As  the  pH  varies
epending  on  the  energy  content  of  HM,  it  is  suggested  that
A  is  also  directly  inﬂuenced  by  the  lipid  content  of  the  food.
ilk  with  higher  fat  concentrations  has  increased  chances  of
eveloping  high  acidity.18
The  pasteurization  of  HM  with  high  acidity  does  not  aim
o  improve  quality.18 Therefore,  it  is  important  to  know  if
here  was  bacterial  growth  prior  to  this  processing,  as  that
roduces  fermentation  and  acidiﬁcation  of  the  milk,  which
n  turn  lead  to  a  reduction  in  nutritional  and  immunological
omponents  inherent  to  the  food,  disqualifying  its  use.12,13,19
Acidiﬁed  HM  cannot  meet  the  speciﬁc  nutritional  needs
f  very-low  birth  weight  or  immunologically-vulnerable
reterm  infants.  The  high  acidity  and  the  release  of  pro-
ons  originating  from  the  ionization  of  lactic  acid  in  an
queous  medium  cause  destabilization  of  soluble  proteins
nd  casein  micelles,  favoring  its  coagulation;  increase  the
smolarity;  alter  the  ﬂavor  (taste  and  smell);  and  reduce
he  immunological  value  of  the  food.  This  cationic  attack,
y  destabilizing  the  casein  in  suspension  in  HM,  impairs
he  availability  of  the  calcium  and  phosphorus  content,
hich  are  chemically  associated  to  casein,  creating  sta-
le  micelles,  thus  making  the  absorption  of  these  minerals
ependent  on  the  protein  digestion  process.19--21
In  this  study,  the  DA  found  in  raw  HM  (3.8◦ D  ±  1.3)  showed
o  statistical  difference  when  compared  with  that  in  pas-
eurized  HM  (3.6◦ D  ±  1.2),  suggesting  that  the  analyzed
ilks  were  adequate  for  consumption  by  newborns,  with  no
urther  interference  of  the  initial  DA  values  on  the  nutri-
ional  content  of  the  food.After  the  addition  of  the  nutritional  supplement  to
M  pasteurized  and  heated  to  37 ◦C,  there  was  a  signiﬁ-
ant  increase  in  the  mean  DA  (18.6◦ D  ±  2.2,  p  <  0.05).  This
ncrease  was  maintained  even  after  30  min  post-dilution
t
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o.05).
17.8◦ D  ±  2.2,  p  <  0.05).  Both  means  were  higher  than  the
◦ D  limit  recommended  for  HM  consumption  by  newborns.
Considering  the  importance  of  HM  acidity  on  its  nutri-
ional  quality,  it  should  be  emphasized  that  acid  or  alkaline
verloads  result  in  metabolic  acidosis  or  alkalosis,  and  its  use
an  cause  necrotizing  enterocolitis  in  very-low  birth  weight
reterm  infants.18
It  is  important  to  emphasize  that  the  HM  (either  raw
r  pasteurized  and  frozen)  can  undergo  lipolysis,  releasing
reater  amounts  of  free  fatty  acids,  which  contribute  to  the
ncrease  in  acidity,  as  interpreted  by  Novak  and  Cordeiro.22
onsequently,  higher  concentrations  of  these  components  in
he  milk,  combined  with  the  high  supply  of  minerals  such  as
alcium  through  the  addition  of  supplements,  would  result
n  the  formation  of  insoluble  soaps,  another  factor  contrary
o  the  absorption  of  the  mineral  by  the  body.6 Also,  it  is
easonable  to  suggest  that,  despite  being  the  same  event
increase  in  DA),  when  promoted  by  different  reasons  (such
s  the  occurrence  of  lipolysis,  the  increase  of  acidifying  com-
onents  due  to  HM  supplementation,  or  the  development  of
cidity  through  the  formation  of  lactic  acid  as  the  result  of
acterial  activity),  it  is  not  possible  to  afﬁrm  that  the  con-
equences  are  the  same,  especially  as  to  interfering  with
alcium  bioavailability  and  metabolism  of  preterm  recep-
ors.  Therefore,  further  studies  on  the  subject  are  required
o  clarify  these  issues.
Furthermore,  the  use  of  multicomponent  HM  supple-
ents  may  increase  the  risk  of  infection  by  contamination
econdary  to  the  manipulation  of  the  supplement  powder
nd  cause  changes  in  food  osmolarity,  affecting  the  absorp-
ion  of  its  nutrients.23 In  this  respect,  a  limitation  of  the
resent  study  is  related  to  the  absence  of  microbiological
ests  to  rule  out  the  possibility  of  contamination  by  the  sup-
lement,  as  well  as  the  previous  lack  of  knowledge  on  the
roduct  acidity,  conditions  that  could  inﬂuence  the  inter-
retation  of  the  results  found  here.
Conversely,  studies  have  emphasized  that  the  increase
n  osmolarity  in  HM  caused  by  addition  of  these  supple-
ents  would  be  related  to  the  development  of  necrotizing
nterocolitis  in  preterm  infants  by  increasing  the  content
f  solutes,  which  is  also  reinforced  by  the  activity  of  human
mylase.  The  enzyme,  present  and  active  in  pasteurized  HM,
hen  acting  on  the  carbohydrates  (dextrins)  that  consti-
ute  the  supplement  degrades  them  into  monosaccharides
nd  oligosaccharides  in  osmolarity  to  more  or  less  time
s  the  carbohydrate  source,  modulating  the  increase  in
smolarity.24,25
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However,  the  HM  supplementation  offered  to  preterm
infants  becomes  important  considering  the  ﬁndings  that
breast  milk  from  their  nursing  mothers,  even  with  a  dif-
ferent  composition  in  relation  to  the  milk  of  mothers  of
full-term  newborns,  still  has  insufﬁcient  protein,  calcium,
and  phosphorus  contents.23,26
In  a  systematic  review  carried  out  by  the  Cochrane
Database  of  Systematic  Reviews,  it  was  concluded  that  the
multicomponent  supplementation  of  HM  for  preterm  infants
was  associated  with  a  quicker  increase  in  weight,  length,  and
head  circumference,  although  no  effects  were  observed  on
bone  mineralization  in  the  assessed  group.27
In  a  study  carried  out  in  2010  in  the  intensive  care  unit  of
a  hospital  in  Porto  Alegre,  state  of  Rio  Grande  do  Sul,  Brazil,
the  authors  compared  two  groups  of  19  preterm  infants:
one  group  received  only  HM  and  the  other  received  the  HM
supplemented  with  FM85®,  milk  fortiﬁer  (FM  85®, Nestlé,
München,  Germany).  Both  groups  were  followed  regarding
the  individual  anthropometric  measurements,  whereas  bone
mineralization  was  assessed  by  whole-body  bone  densito-
metry  with  dual  energy  X-ray  absorptiometry  (DEXA)  and
laboratory  tests  of  alkaline  phosphatase  control,  calcium,
phosphorus,  as  well  as  urinary  calcium  and  phosphorus.  The
results  showed  a  clear  improvement  in  the  supplemented
group  when  compared  with  the  non-supplemented  group;  a
decrease  in  alkaline  phosphatase  was  also  observed  in  the
latter  group,  demonstrating  better  mineral  homeostasis  in
this  situation.28
Many  studies  on  HM  supplementation  for  preterm  infants
with  bone  mineralization  deﬁcits  have  been  developed  to
demonstrate  the  consequences  of  this  conduct  for  this
speciﬁc  population.6,8,9,19 However,  the  results  are  still
conﬂicting,  sometimes  showing  beneﬁts  for  mineralization,
sometimes  showing  no  signiﬁcant  responses  when  compared
to  HM  without  supplementation  and/or  speciﬁc  formu-
las  for  preterm  infants.  However,  it  must  be  considered
that  the  methodologies  used  to  assess  these  outcomes  are
quite  diverse  --  ranging  from  the  ‘‘classic’’  investigation
based  on  anthropometric  data,  X-rays,  and  serum  biochem-
ical  analysis  of  calcium,  phosphorus,  alkaline  phosphatase,
parathyroid  hormone,  vitamin  D  metabolites,  calcium,  and
phosphorus  in  urine;  or  more  recently,  by  DEXA  --  making
it  difﬁcult  to  compare  the  ﬁndings.  Moreover,  the  different
types  of  supplementation  used  in  HM  and  the  sample  size
(usually  small)  are  obstacles  to  attain  consistent  conclusions
from  previously  performed  studies.28
Thus,  the  present  study  is  relevant,  as  it  proposed
the  observation  of  acid--basic  characteristics  of  supple-
mented  HM  in  vitro, reducing  the  inﬂuences  caused  by
metabolic  activity  in  vivo, which  can  become  confounding
factors  when  interpreting  results  about  the  physicochemi-
cal  food  modiﬁcations  after  supplementation.  Nonetheless,
the  methodology  used  here  did  not  allow  for  a  direct  assess-
ment  of  the  consequences  of  increased  DA  in  supplemented
HM  on  calcium  and  phosphorus  bioavailability,  or  the  under-
standing  of  their  effects  on  the  health  and  metabolism  of
very-low  birth  weight  preterm  infants  and/or  those  under-
going  treatment  for  metabolic  bone  diseases.Therefore,  considering  the  results  obtained  in  this  study,
which  showed  no  signiﬁcant  difference  between  the  initial
DA  of  raw  and  pasteurized  HM,  as  well  as  the  signiﬁcant
acidiﬁcation  of  supplemented  HM  (used  for  preterm  infants503
ith  very-low  birth  weight  and/or  in  cases  of  metabolic  bone
iseases),  and  given  the  speculation  that  this  acidiﬁcation
bserved  in  the  supplemented  HM  may  hinder  the  absorption
f  nutrients  such  as  calcium,  it  must  be  emphasized  that
here  is  not  enough  evidence  from  the  scientiﬁc  literature
o  sustain  such  assertion.  Therefore,  further  studies,  includ-
ng  methodologies  that  will  allow  assessing  the  occurrence
f  metabolic  bone  disease  in  very-low  birth  weight  preterm
nfants  receiving  supplemented  and  non-supplemented  HM,
ith  and  without  DA  increase  in  the  consumed  milk,  are  rec-
mmended  in  order  to  demonstrate  the  effectiveness  and
afety  of  supplementation,  which  are  not  yet  fully  clariﬁed.
Consequently,  such  studies  are  also  essential  to  indi-
ate  the  optimal  composition  of  HM  supplements  used
o  feed  these  preterm  infants.  Considering  that  the  con-
equences  of  HM  supplementation  remain  questionable,
ndications/prescriptions  always  require  critical  accuracy.
Furthermore,  considering  the  results  discussed  in  the
resent  study,  it  is  worth  emphasizing  the  contrast  between
he  initial  disposal  of  HM  samples  carried  out  in  HMB  due  to
he  presence  of  DA  >  8◦ D,  which  is  interpreted  as  an  increase
n  the  production  of  lactic  acid  due  to  biological  contami-
ation  of  food,  and  the  elevation  of  this  parameter  in  HM
aused  by  addition  of  the  nutritional  supplement,  suggest-
ng  that  samples  with  high  DA  discarded  by  HMBs  would
ot  always  be  justiﬁed  by  high  contamination,  and  could
herefore  be  caused  by  changes  in  the  chemical  compo-
ition  of  the  food  itself,  as  proposed  by  a  previous  study.
herefore,  further  discussion  is  necessary  to  propose  solu-
ions  to  minimize  the  disposal  of  HM  supposedly  adequate
or  consumption.
onﬂicts of interest
he  authors  declare  no  conﬂicts  of  interest.
eferences
1. Sá Neto JA, Rodrigues BM. Tecnologia como fundamento do
cuidar em Neonatologia. Texto Contexto Enferm, Florianópolis.
2010;19:372--7.
2. Braga LP, Palhares DB. Effect of evaporation and pasteurization
in the biochemical and immunological composition of human
milk. J Pediatr (Rio J). 2007;83:59--63.
3. Brasil, Ministério da Saúde, Secretaria de Atenc¸ão à Saúde,
Departamento de Ac¸ões Programáticas e Estratégicas. Atenc¸ão
à saúde do recém-nascido: guia para os proﬁssionais de saúde:
cuidados com o recém-nascido pré-termo, v.4. Brasília: Min-
istério da Saúde; 2011 (Série A: Normas e Manuais Técnicos).
4. Arslanoglu S, Ziegler EE, Moro GE. WAPM Working Group
on Nutrition. Recommendations and guidelines for perinatal
practice. Donor human milk in preterm infant feeding: evidence
and recommendations. J Perinat Med. 2010;38:347--51.
5. World Health Organization. Essential nutrition actions: improv-
ing maternal, newborn, infant and young child health and
nutrition. Geneva: World Health Organization; 2013. p. 144.
6. Mataloun MM, Leone CR, Ono N, Vaz FA. Repercussões neonatais
do uso de leite materno com aditivos e fórmula para pré-termo
em recém-nascidos de muito baixo peso ao nascer. Pediatr (São
Paulo). 2004;26:247--56.
7. Silva RK, Souza NL, Silva RA, Silva JB, Ladisláo NB, Oliveira SI.
O ganho de peso em prematuros relacionado ao tipo de leite.
Rev Eletr Enf. 2014;16:535--41.
51
1
1
1
1
1
1
1
1
1
2
2
2
2
2
2
2
2
204  
8. Martins EC, Krebs VL. Effects of the use of fortiﬁed raw mater-
nal milk on very low birth weight infants. J Pediatr (Rio J).
2009;85:157--62.
9. Tanaka A, Rugolo LM, Miranda AF, Trindade CE. Fractional
sodium excretion, urinary osmolality and speciﬁc gravity in
preterm infants fed with fortiﬁed donor human milk. J Pediatr
(Rio J). 2006;82:335--40.
0. Tavares LV [Dissertation] Determinac¸ão de aminoácidos em
RNPT alimentados com dietas modiﬁcadas de leite humano.
Campo Grande, MS: Universidade Federal do Mato Grosso do
Sul; 2011.
1. World Health Organization. Guidelines on optimal feeding of
low birth-weight infants in low-and middle-income countries.
Geneva: World Health Organization; 2011.
2. Almeida JA, Guimarães V, Novak FR. Normas técnicas Redeblh-
Br para bancos de leite humano: selec¸ão e classiﬁcac¸ão. Rio de
Janeiro: FIOCRUZ/IFF-BLH; 2005.
3. Brasil, Agência Nacional de Vigilância Sanitária. Banco de
leite humano: funcionamento, prevenc¸ão e controle de riscos.
Brasília: Anvisa; 2008 (Série Tecnologia em Servic¸os de Saúde).
4. Trindade CE. Importância dos minerais na alimentac¸ão do pré-
termo extremo. J Pediatr (Rio J). 2005;81:S43--51.
5. American Academy of Pediatrics. Calcium and vitamin D
requirements of enterally fed preterm infants: guidance for
the clinician in rendering pediatric care. Pediatrics. 2013;131:
e1676. Available from: http://www.sbp.com.br/pdfs/CLINICAL
REPORT-Calcium Vitamin D Requirements Enterally Fed
Preterm Infants.pdf [accessed 08.08.15].
6. Costa EC [Dissertation] Caracterizac¸ão microbiológica e físico-
química de leite humano em diferentes períodos de lactac¸ão.
Vic¸osa (MG): Universidade Federal de Vic¸osa; 2012.
7. Grazziotin MC [Dissertation] Efeito dos diferentes modos e
tempos de estocagem sobre a acidez e o valor calórico do leite
humano ordenhado cru de mães com recém nascidos internados
numa unidade de neonatologia. Curitiba: Universidade Federal
do Paraná; 2014.8. Cavalcante JL, Telles FJ, Peixoto MM, Rodrigues RC. Uso
da acidez titulável no controle de qualidade do leite
humano ordenhado. Ciênc Tecnol Aliment (Campinas). 2005;25:
103--8.Pereira  CI  et  al.
9. Rona MSS, Novak FR, Portilho M, Pelissari FM, Martins ABT, Mati-
oli G. Efeito do tempo e da temperatura de estocagem nas
determinac¸ões de acidez, cálcio, proteínas e lipídeos de leite
de doadoras de bancos de leite humano. Rev Bras Saude Mater
Infant. 2008;8:257--63.
0. Pessoto MA [Thesis] Avaliac¸ão da lactac¸ão em mães de recém-
nascido pretermo com peso de nascimento inferior a 1.250
gramas segundo diferentes métodos de ordenha: manual, com
bomba manual ou com bomba elétrica. Campinas, SP: Universi-
dade Estadual de Campinas; 2009.
1. Aprile MM [Dissertation] Crescimento de recém-nascidos de
muito baixo peso alimentados com leite de banco de leite
humano selecionado segundo o valor calórico e proteico. São
Paulo, SP: Universidade de São Paulo; 2006.
2. Novak FR, Cordeiro DM. The correlation between aero-
bic mesophilic microorganism counts and Dornic acidity in
expressed human breastmilk. J Pediatr (Rio J). 2007;83:87--91.
3. Cukier FN [Dissertation] Eﬁcácia e seguranc¸a dos aditivos de
leite humano para prematuros com peso de nascimento ≤ 1500 g
ou idade gestacional ≤ 34 semanas: uma revisão sistemática
com metanálise. Rio de Janeiro, RJ: Fundac¸ão Oswaldo Cruz,
Instituto Nacional de Saúde da Mulher, da Crianc¸a e do Adoles-
cente Fernandes Figueira; 2014.
4. De Curtis M, Candusso M, Pieltain C, Rigo J. Effect of fortiﬁ-
cation on the osmolality of human milk. Arch Dis Child Fetal
Neonatal Ed. 1999;8:F141--3.
5. Agarwal R, Singal A, Aggarwal R, Deorari AK, Paul VK. Effect of
fortiﬁcation with human milk fortiﬁer (HMF) and other fortifying
agents on the osmolality of preterm breast milk. Indian Pediatr.
2004;41:63--7.
6. Tudehope DI. Human milk and the nutritional needs of preterm
infants. J Pediatr. 2013;162:S17--25.
7. Kuschel CA, Harding JE. Multicomponent fortiﬁed human milk
for promoting growth in preterm infants. Cochrane Database
Syst Rev. 2004;1:1--6.
8. Einloft PR [Thesis] Leite humano suplementado versus leite
humano suplementado na alimentac¸ão de recém-nascidos de
muito baixo peso: efeitos sobre a mineralizac¸ão óssea e o cresci-
mento. Porto Alegre: Pontifícia Universidade Católica do Rio
Grande do Sul; 2010.
